Evidence map›Paper›PMID 26483543›Full record

ArticleThe Journal of biological chemistry2015

The Hydroxyl Side Chain of a Highly Conserved Serine Residue Is Required for Cation Selectivity and Substrate Transport in the Glial Glutamate Transporter GLT-1/SLC1A2.

Alexandre Simonin, Nicolas Montalbetti, Gergely Gyimesi, Jonai Pujol-Giménez, Matthias A Hediger

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexandre SimoninFrom the Institute of Biochemistry and Molecular Medicine and Swiss National Center of Competence in Research, National Center of Competence in Research (NCCR) TransCure, University of Bern, 3012 Bern, Switzerland asimonin@hotmail.fr.
Nicolas MontalbettiFrom the Institute of Biochemistry and Molecular Medicine and Swiss National Center of Competence in Research, National Center of Competence in Research (NCCR) TransCure, University of Bern, 3012 Bern, Switzerland nim71@pitt.edu.
Gergely GyimesiFrom the Institute of Biochemistry and Molecular Medicine and Swiss National Center of Competence in Research, National Center of Competence in Research (NCCR) TransCure, University of Bern, 3012 Bern, Switzerland.
Jonai Pujol-GiménezFrom the Institute of Biochemistry and Molecular Medicine and Swiss National Center of Competence in Research, National Center of Competence in Research (NCCR) TransCure, University of Bern, 3012 Bern, Switzerland.
Matthias A HedigerFrom the Institute of Biochemistry and Molecular Medicine and Swiss National Center of Competence in Research, National Center of Competence in Research (NCCR) TransCure, University of Bern, 3012 Bern, Switzerland matthias.hediger@ibmm.unibe.ch.
University of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutamate transporters maintain synaptic concentration of the excitatory neurotransmitter below neurotoxic levels. Their transport cycle consists of cotransport of glutamate with three sodium ions and one proton, followed by countertransport of potassium. Structural studies proposed that a highly conserved serine located in the binding pocket of the homologous GltPh coordinates L-aspartate as well as the sodium ion Na1. To experimentally validate these findings, we generated and characterized several mutants of the corresponding serine residue, Ser-364, of human glutamate transporter SLC1A2 (solute carrier family 1 member 2), also known as glutamate transporter GLT-1 and excitatory amino acid transporter EAAT2. S364T, S364A, S364C, S364N, and S364D were expressed in HEK cells and Xenopus laevis oocytes to measure radioactive substrate transport and transport currents, respectively. All mutants exhibited similar plasma membrane expression when compared with WT SLC1A2, but substitutions of serine by aspartate or asparagine completely abolished substrate transport. On the other hand, the threonine mutant, which is a more conservative mutation, exhibited similar substrate selectivity, substrate and sodium affinities as WT but a lower selectivity for Na(+) over Li(+). S364A and S364C exhibited drastically reduced affinities for each substrate and enhanced selectivity for L-aspartate over D-aspartate and L-glutamate, and lost their selectivity for Na(+) over Li(+). Furthermore, we extended the analysis of our experimental observations using molecular dynamics simulations. Altogether, our findings confirm a pivotal role of the serine 364, and more precisely its hydroxyl group, in coupling sodium and substrate fluxes.

Indexed as

Amino Acid SubstitutionAnimalsCell MembraneExcitatory Amino Acid Transporter 2Glutamate Plasma Membrane Transport ProteinsHEK293 CellsHumansIon TransportLithiumMutation, MissenseOocytesSerineSodiumXenopus laevisExcitatory Amino Acid Transporter 2Glutamate Plasma Membrane Transport ProteinsLithiumSerineSLC1A2 protein, humanSodiumexcitatory neurotransmissionexcitotoxicityGLT-1glutamate transportermolecular dynamicsmutagenesisneurotoxicityneurotransmitter transportSLC1A2structure-functionstructure/function studies

Identifiers

PMID26483543
PMCPMC4683268
OpenAlexW1748331196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.